Muscular Dystrophy Association’s Funding of Foundational Research Leads to New FDA Approved Treatment Duvyzat (givinostat) for Duchenne Muscular Dystrophy
March 21, 2024 19:45 ET
|
Muscular Dystrophy Association
New York, March 21, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association’s funding of foundational research leads to new drug approval by the US Food and Drug Administration (FDA) of Duvyzat...
Global Multiomics Market Poised for Significant Growth, Asia Pacific Projected to Surge at Fastest CAGR by 2034
March 21, 2024 07:50 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Global Multiomics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The study conducts a...
Cell Cryopreservation Market Forecast 2024-2029: Europe Set to Command Significant Share Amid Increasing Scientific Advancements
March 18, 2024 05:12 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Cell Cryopreservation Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The cell cryopreservation...
Biobanking Market Report 2024-2034 - Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
February 29, 2024 04:12 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Biobanking Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biobanking Market is forecast to surpass...
Cell Based Assay Market Research Unveils High Content Screening Innovations and Industry Forecasts 2024-2028
February 27, 2024 03:48 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. 2024 to 2028" report has...
Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference
February 15, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific...
Europe Cell Penetrating Peptide Market Analysis Report 2023-2030: With the Advent of CRISPR-Cas9, there is a Growing Trend to Leverage CPPs for Intracellular Delivery of Gene-editing Tools
February 14, 2024 11:43 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Europe Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By End-use, By Application (Drug Delivery, Gene Delivery, Diagnostics,...
Flow Cytometry in Oncology and Immunology Market Set for Growth Amid Increasing Global Cancer Prevalence
January 24, 2024 13:24 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry in Oncology and Immunology Market Report 2023" report has been added to ResearchAndMarkets.com's offering. As per the latest...
Drug Development Online Course: Key to Success from Concept to Commercialization - Earn Up to 8 Credits Towards RAC Recertification Upon Full Completion
January 17, 2024 10:33 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization" training has been added to ResearchAndMarkets.com's offering.Join Top Drug...
Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA
October 26, 2023 16:24 ET
|
Muscular Dystrophy Association
New York, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of AGAMREE® (vamorolone), a structurally unique...